NEPHROGENEX

nephrogenex-logo

NephroGenex is a drug-development company focusing on kidney disease. The Company is developing Pyridorinâ„¢ (pyridoxamine dihydrochloride) as a treatment to slow the progression of diabetic kidney disease.

#SimilarOrganizations #People #Financial #Website #More

NEPHROGENEX

Industry:
Biotechnology Diabetes Health Care

Founded:
2004-01-01

Address:
Princeton, New Jersey, United States

Country:
United States

Website Url:
http://www.nephrogenex.com

Total Employee:
11+

Status:
Active

Contact:
609-986-1780

Total Funding:
21.8 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt WordPress Domain Not Resolving Wordpress Plugins Euro Organization Schema


Similar Organizations

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.


Current Advisors List

not_available_image

Wesley Fox Advisor @ NephroGenex
Advisor

Current Employees Featured

not_available_image

Wesley Fox
Wesley Fox Co-Founder, Chief Executive Officer & President @ NephroGenex
Co-Founder, Chief Executive Officer & President

Founder


not_available_image

Wesley Fox

Stock Details


Company's stock symbol is NASDAQ:NRX

Investors List

east-west-bank_image

East West Bank

East West Bank investment in Post-IPO Equity - NephroGenex

care-capital_image

Care Capital

Care Capital investment in Series A - NephroGenex

biostratum_image

BioStratum

BioStratum investment in Series A - NephroGenex

vanderbilt-university-office-of-investments_image

Vanderbilt University Office of Investments

Vanderbilt University Office of Investments investment in Series A - NephroGenex

Official Site Inspections

http://www.nephrogenex.com

  • Host name: 104.21.88.106
  • IP address: 104.21.88.106
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "NephroGenex"

NephroGenex, Inc

NephroGenex is an innovator in the development of drugs to treat kidney disease, with a first indication in diabetic nephropathy. Our clinical and regulatory teams positioned the Phase 3 …See details»

Board of Directors - nephrogenex.com

Pierre Legault joined NephroGenex in October 2013 as Chief Executive Officer and has been a member of the Company’s Board of Directors since November 2012. ... Mitchum is the CEO of …See details»

Company Overviewcompany/ - nephrogenex.com

NephroGenex is applying the latest advances in molecular profiling technologies to unravel the complex pathologies found in kidney disease, and overcome long standing obstacles for drug …See details»

NephroGenex Company Profile | Management and Employees List

NephroGenex Profile and History. NephroGenex Inc. is a pharmaceutical company which is focused on the development of therapeutics to treat kidney diseases caused by pathogenic …See details»

Nephrogenex Overview | SignalHire Company Profile

Nephrogenex is a private company that has been in the industry for 19 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals areas. ... Organization Website: …See details»

NEPHROGENEX INC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for NEPHROGENEX INC of Cary, NC. Get the latest business insights from Dun & Bradstreet.See details»

NephroGenex - Funding, Financials, Valuation & Investors

NephroGenex is registered under the ticker NASDAQ:NRX . Their stock opened with $12.00 in its Feb 11, 2014 IPO. Stock Symbol NASDAQ:NRX ; Valuation at IPO $106.2M; Money Raised at …See details»

NephroGenEx.com specializes in the development of drugs for …

Nephrogenex Inc. - Applying Molecular Profiling to Kidney Disease Description. Excerpted from the website: Treatment of end stage renal disease (ESRD) accounts for up to 15% of the …See details»

NephroGenex - Overview, News & Similar companies - ZoomInfo

NephroGenex Inc. is a pharmaceutical company which is focused on the development of therapeutics to treat kidney diseases caused by pathogenic oxidative chemistries. Diabetic …See details»

NephroGenex - Company Profile - Tracxn

Sep 3, 2024 NephroGenex is a clinical-stage pharmaceutical company developing therapeutics to treat kidney diseases. Product pipeline includes an oral formulation of Pyridorin, which is …See details»

Management Team - nephrogenex.com

Pierre Legault Chief Executive Officer and President Pierre Legault joined NephroGenex in October 2013 as Chief Executive Officer and has been a member of the Company’s Board of …See details»

NephroGenex - Contacts, Employees, Board Members, Advisors

NephroGenex has 1 current employee profile, Co-Founder, Chief Executive Officer & President Wesley Fox. NephroGenex has 1 board member or advisor, Wesley Fox . ContactsSee details»

NephroGenex, Inc. | VentureRadar

NephroGenex is developing pharmaceuticals against certain kidney diseases. ... Find out more about NephroGenex, Inc., Healthtech, Biotech, Biotechnology, Therapeutics, Healthtech and …See details»

NephroGenex - Products, Competitors, Financials, Employees ...

NephroGenex is a pharmaceutical company focused on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. Since its inception, the company …See details»

NephroGenex Company Profile - Office Locations, Competitors

NephroGenex is a company operating an online store that provides customers with a range of medications. It offers oncology, endocrinology, gynecology, cardiology, ophthalmology, …See details»

NephroGenex CEO, Founder, Key Executive Team, Board of …

NephroGenex has 2 board of directors, including Mark Leschly. Name. Firm. Work History. Other Seats. Mark Leschly. Mark Leschly is a Managing Director of Iconica Partners and a Managing …See details»

About Us - nephrogenex.com

NephroGenex is an innovator in the development of drugs to treat kidney disease, with a first indication in diabetic nephropathy. We have been pioneering the development of …See details»

NephroGenex sold assets to Medpace Research - Cassel Salpeter

May 1, 2017 Background: NephroGenex, headquartered in Raleigh, NC, is a specialty pharmaceutical Company that focused on the development of therapeutics to treat kidney …See details»

HHS Announces Winners of the $7.25 Million KidneyX ... - HHS.gov

19 hours ago Prizes for innovations to reduce water or power used during dialysis. Today, the U.S. Department of Health and Human Services (HHS) announced seven winners of the …See details»

NücleoGenex

We're on a mission to provide the best products that can help you change your health and wellness for the better, on a cellular level, with state-of-the-art formulations and raw materials, …See details»

linkstock.net © 2022. All rights reserved